Chemoprevention and inhibition of P-glycoprotein in cancer cells by Chinese medicinal herbs
Many of the herbal extracts used in the Chinese clinical medical routine inhibit the growth of tumor cells. In the present work, extracts of 12 selected herbs were prepared with methanol, chloroform, ethyl acetate and water, and the effects of these on the multidrug resistance (MDR) and P‐glycoprote...
Saved in:
Published in | Phytotherapy research Vol. 22; no. 12; pp. 1671 - 1676 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Chichester, UK
John Wiley & Sons, Ltd
01.12.2008
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Many of the herbal extracts used in the Chinese clinical medical routine inhibit the growth of tumor cells. In the present work, extracts of 12 selected herbs were prepared with methanol, chloroform, ethyl acetate and water, and the effects of these on the multidrug resistance (MDR) and P‐glycoprotein of mouse lymphoma cells transfected with the human mdr1 gene and on a human lung alveolar epithelial cell line were investigated. The extracts were tested for antiproliferative effects, and the reversal of MDR in mouse lymphoma cells. The possible chemopreventive effect of the chloroform extracts was studied on the expression of cytomegalovirus (CMV) immediate‐early (IE) antigen in human lung cancer cells (A549). The antimicrobial effects of the extracts were tested on some representative micro‐organisms. Certain of the chloroform extracts of the plant materials were the most effective compounds on the reversal of MDR. Two of the chloroform extracts enhanced the antiproliferative effect of doxorubicin on MDR mouse lymphoma cells. The selected extracts did not show any antibacterial effect with the agar diffusion method. Certain chloroform extracts decreased the intermediate IE antigen expression of CMV in A459 cells. Copyright © 2008 John Wiley & Sons, Ltd. |
---|---|
Bibliography: | istex:1DD39C62B159BD2817CEF4E1B5D4B5E03B25DC46 ark:/67375/WNG-DRD4SWL6-0 Szeged Foundation Foundation for Cancer Research of the Hungarian Ministry of Health (Szegedi Rákkutatásért Alapítvány) Grant No. ETT 07/1999/2000 and the Hungarian-Chinese Bilateral Research Cooperation (TéT/CHN-17/04) ArticleID:PTR2554 ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ISSN: | 0951-418X 1099-1573 |
DOI: | 10.1002/ptr.2554 |